vs

Side-by-side financial comparison of Ecovyst Inc. (ECVT) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $199.4M, roughly 2.0× Ecovyst Inc.).

Ecovyst Inc. is a global sustainable specialty materials provider that develops and manufactures high-performance catalysts and functional additives. Its offerings serve key segments including industrial manufacturing, consumer goods, and environmental protection, helping clients improve operational efficiency and lower carbon emissions across North America, Europe, and Asia-Pacific markets.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

ECVT vs GRDN — Head-to-Head

Bigger by revenue
GRDN
GRDN
2.0× larger
GRDN
$397.6M
$199.4M
ECVT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECVT
ECVT
GRDN
GRDN
Revenue
$199.4M
$397.6M
Net Profit
$20.9M
Gross Margin
23.4%
21.5%
Operating Margin
10.9%
7.7%
Net Margin
5.3%
Revenue YoY
34.0%
Net Profit YoY
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECVT
ECVT
GRDN
GRDN
Q4 25
$199.4M
$397.6M
Q3 25
$204.9M
$377.4M
Q2 25
$176.1M
$344.3M
Q1 25
$143.1M
$329.3M
Q4 24
$148.9M
Q3 24
$153.9M
$314.4M
Q2 24
$154.0M
Q1 24
$141.6M
Net Profit
ECVT
ECVT
GRDN
GRDN
Q4 25
$20.9M
Q3 25
$-79.3M
$9.8M
Q2 25
$6.0M
$9.0M
Q1 25
$-3.6M
$9.4M
Q4 24
Q3 24
$14.3M
$-122.0M
Q2 24
$8.3M
Q1 24
$1.2M
Gross Margin
ECVT
ECVT
GRDN
GRDN
Q4 25
23.4%
21.5%
Q3 25
25.4%
19.8%
Q2 25
22.8%
19.8%
Q1 25
13.3%
19.5%
Q4 24
28.9%
Q3 24
29.3%
19.4%
Q2 24
27.3%
Q1 24
23.5%
Operating Margin
ECVT
ECVT
GRDN
GRDN
Q4 25
10.9%
7.7%
Q3 25
13.8%
4.3%
Q2 25
9.0%
3.7%
Q1 25
-0.7%
3.9%
Q4 24
15.1%
Q3 24
17.9%
-33.3%
Q2 24
14.1%
Q1 24
9.5%
Net Margin
ECVT
ECVT
GRDN
GRDN
Q4 25
5.3%
Q3 25
-38.7%
2.6%
Q2 25
3.4%
2.6%
Q1 25
-2.5%
2.9%
Q4 24
Q3 24
9.3%
-38.8%
Q2 24
5.4%
Q1 24
0.9%
EPS (diluted)
ECVT
ECVT
GRDN
GRDN
Q4 25
$0.06
Q3 25
$-0.69
Q2 25
$0.05
Q1 25
$-0.03
Q4 24
$-0.26
Q3 24
$0.12
Q2 24
$0.07
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECVT
ECVT
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$197.2M
$65.6M
Total DebtLower is stronger
$392.6M
$0
Stockholders' EquityBook value
$603.4M
$217.9M
Total Assets
$1.3B
$412.7M
Debt / EquityLower = less leverage
0.65×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECVT
ECVT
GRDN
GRDN
Q4 25
$197.2M
$65.6M
Q3 25
$82.0M
$36.5M
Q2 25
$69.6M
$18.8M
Q1 25
$127.5M
$14.0M
Q4 24
$131.4M
Q3 24
$123.5M
$37.2M
Q2 24
$83.3M
Q1 24
$103.1M
Total Debt
ECVT
ECVT
GRDN
GRDN
Q4 25
$392.6M
$0
Q3 25
$854.8M
Q2 25
$856.6M
Q1 25
$859.0M
Q4 24
$860.8M
Q3 24
$862.7M
$34.3M
Q2 24
$862.4M
Q1 24
$866.2M
Stockholders' Equity
ECVT
ECVT
GRDN
GRDN
Q4 25
$603.4M
$217.9M
Q3 25
$607.9M
$195.5M
Q2 25
$692.4M
$179.7M
Q1 25
$698.7M
$163.2M
Q4 24
$700.5M
Q3 24
$729.4M
$133.9M
Q2 24
$717.3M
Q1 24
$711.4M
Total Assets
ECVT
ECVT
GRDN
GRDN
Q4 25
$1.3B
$412.7M
Q3 25
$1.7B
$390.0M
Q2 25
$1.8B
$356.3M
Q1 25
$1.8B
$334.0M
Q4 24
$1.8B
Q3 24
$1.8B
$348.0M
Q2 24
$1.8B
Q1 24
$1.8B
Debt / Equity
ECVT
ECVT
GRDN
GRDN
Q4 25
0.65×
0.00×
Q3 25
1.41×
Q2 25
1.24×
Q1 25
1.23×
Q4 24
1.23×
Q3 24
1.18×
0.26×
Q2 24
1.20×
Q1 24
1.22×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECVT
ECVT
GRDN
GRDN
Operating Cash FlowLast quarter
$41.8M
$34.6M
Free Cash FlowOCF − Capex
$22.9M
FCF MarginFCF / Revenue
11.5%
Capex IntensityCapex / Revenue
9.4%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$69.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECVT
ECVT
GRDN
GRDN
Q4 25
$41.8M
$34.6M
Q3 25
$55.3M
$28.2M
Q2 25
$33.0M
$19.9M
Q1 25
$10.3M
$17.6M
Q4 24
$43.5M
Q3 24
$59.9M
Q2 24
$10.0M
Q1 24
$36.5M
Free Cash Flow
ECVT
ECVT
GRDN
GRDN
Q4 25
$22.9M
Q3 25
$53.2M
$24.2M
Q2 25
$7.8M
Q1 25
$-14.0M
Q4 24
$30.9M
Q3 24
$53.6M
Q2 24
$-9.3M
Q1 24
$19.1M
FCF Margin
ECVT
ECVT
GRDN
GRDN
Q4 25
11.5%
Q3 25
26.0%
6.4%
Q2 25
4.4%
Q1 25
-9.8%
Q4 24
20.7%
Q3 24
34.9%
Q2 24
-6.1%
Q1 24
13.5%
Capex Intensity
ECVT
ECVT
GRDN
GRDN
Q4 25
9.4%
Q3 25
1.0%
1.1%
Q2 25
14.4%
Q1 25
16.9%
Q4 24
8.5%
Q3 24
4.1%
Q2 24
12.5%
Q1 24
12.3%
Cash Conversion
ECVT
ECVT
GRDN
GRDN
Q4 25
1.65×
Q3 25
2.87×
Q2 25
5.52×
2.21×
Q1 25
1.86×
Q4 24
Q3 24
4.21×
Q2 24
1.20×
Q1 24
29.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECVT
ECVT

Industrial Mining Automotive$101.3M51%
Regeneration And Treatment Services$90.0M45%
Other$8.1M4%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons